 |
|
4 Steps
Maximum: 4 CME cr.
0 new discussion posts (1 published)
Sign in to view your progression
|
Program Overview
Progr...
Learning Objectives
Learn...
Target Audience
Targe...
Disclosure/Disclaimer
Discl...
Since the discovery of BRCA1/2 genes, BRCA genetic testing has been undertaken to assess cancer risk. Due to an increased understanding of the nature of BRCA associated ovarian cancer and new personalised treatments, BRCA testing is now also being undertaken to drive treatment decisions. BRCA testing, however, has many implications for both the patient and their families and must therefore be accompanied by appropriate genetic counselling. This CME module discusses the use of BRCA testing in ovarian cancer management, the role of genetic counselling, together with relevant guidelines/legal requirements and new initiatives for the delivery of genetic counselling services.
COMPONENTS
Online:
2 online interactive, narrated presentations 26 to 30minutes in length
Pre- and post-test questions for each presentation.
COMPONENTS
Online:
2 online interactive, narrated presentations 26 to 30minutes in length
Pre- and post-test questions for each presentation.
Learning objectives:
Upon completion of this module the reader will be able to:
- Understand the relationship and associated risks between BRCA1/2 mutations and ovarian cancer and the impact of BRCA status on management decisions in ovarian cancer
- Know the most up-to-date recommendations with regard to referring ovarian cancer patients for BRCA testing
- Understand the difference between testing for personal/family risk of developing cancer and testing to potentially drive treatment decisions
- Define the role of genetic counselling in BRCA genetic testing
- Know the key guideline recommendations for genetic counselling relating to BRCA testing, including the type of information patients should receive pre- and post-testing
- Appreciate the European legal requirements relating to BRCA testing and genetic counselling
- Be aware of new models that have been evaluated for the delivery of genetic counselling to patients undergoing BRCA testing and their associated benefits and limitations.
Upon completion of this module the reader will be able to:
- Understand the relationship and associated risks between BRCA1/2 mutations and ovarian cancer and the impact of BRCA status on management decisions in ovarian cancer
- Know the most up-to-date recommendations with regard to referring ovarian cancer patients for BRCA testing
- Understand the difference between testing for personal/family risk of developing cancer and testing to potentially drive treatment decisions
- Define the role of genetic counselling in BRCA genetic testing
- Know the key guideline recommendations for genetic counselling relating to BRCA testing, including the type of information patients should receive pre- and post-testing
- Appreciate the European legal requirements relating to BRCA testing and genetic counselling
- Be aware of new models that have been evaluated for the delivery of genetic counselling to patients undergoing BRCA testing and their associated benefits and limitations.
Target Audience
Oncologists, gynaecologists, oncology/gynaecology nurses
Oncologists, gynaecologists, oncology/gynaecology nurses
Disclosures
Dr Judith Balmaña – no potential conflict of interest
Dr Melanie Mackean – potential conflict of interest: Receipt of honoraria or consultation fees: Boehringer Ingelheim, Roche
Acknowledgement of Commercial Support:
No commercial support was received for this enduring material activity.
Dr Judith Balmaña – no potential conflict of interest
Dr Melanie Mackean – potential conflict of interest: Receipt of honoraria or consultation fees: Boehringer Ingelheim, Roche
Acknowledgement of Commercial Support:
No commercial support was received for this enduring material activity.
|
Personal Information
|
|
|
The Patient Pathway and Role of Genetic Counselling in BRCA Testing
|
|
|
New Directions in BRCA Genetic Testing and Counselling
|
|
|
Evaluation Form & CME Certificate
|
|
{{ help_message }}
{{filter}}